August 29th 2023
The first 10 drugs identified for negotiations under the Inflation Reduction Act include several well advertised agents indicated to treat diabetes, heart failure, and other chronic diseases.
August 21st 2023
The newly named centers across the country will work closely with communities to focus research on populations at greatest risk for perinatal morbidity and mortality.
August 15th 2023
Patients with diabetes will be able to save money when ordering insulin and commonly prescribed products, such as continuous glucose monitors and pumps.
Excess CVD mortality among Black vs White adults was diminished after control for behavior/metabolic factors and negligible after adjustments for SDOH, a new study reveals.
August 2nd 2023
A daily dose of clinical news on Patient Care you may have missed.
Daily Dose: Vegetarian Diet Boosts Optimal Drug Therapy in High-Risk CVD Patients
Insulin Prescription Fills Up Following Inflation Reduction Act Cap on Out-of-Pocket Costs
The new policy is helping people who are taking insulin save money and helping others to afford it in the first place, says a study coauthor from the USC Sol Price School of Public Policy .
Vegetarian Diet May Augment Effects of Optimal Drug Therapy in Patients at High Risk of CVD
Reductions in LDL-C, HbA1c, and body weight were associated with a variety of vegetarian diets in participants with or at high risk for cardiovascular disease.
Diabetes- and CVD-Related Mortality Rise after Steady 10-Year Decline
Since 2014, the age-adjusted mortality rate for diabetes and CVD has increased by 1% after an overall decline between 1999 and 2019, new research finds.
Inclisiran Label Expanded to Include Primary Prevention Population
The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.
Statins Appear Beneficial for CV Outcomes in Primary Prevention Patients with HTN without CVD or Diabetes
In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.
ADA Updates Standards of Care, Adding Teplizumab for Delay of T1D, Emphasizing Hepatic Disease Management
The ADA's annual update includes refined criteria for type 1 diabetes screening and detailed guidance on detection and management of NAFLD and NASH.
FDA Awards De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Decline in Kidney Function in Adults with Type 2 Diabetes and Early-Stage Kidney Disease
KidneyIntelX.dkd, a first-in-class AI-enabled prognostic test, stratifies risk of DKD progression in 5 years and is specific for early stage disease.
Take-Home Thoughts for Managing Diabetes
Eden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.
Evaluating the Role of Real-World Evidence Studies
Elizabeth Holt, MD, FACE, and Eden Miller, DO, comment on the pros and cons of real-world data studies, looking particularly at the study of the OneTouch Verio Flex meter and the OneTouch Reveal apps.
Implementing the OneTouch Verio Flex® Meter and OneTouch Reveal® Mobile Application
Experts discuss steps to introduce the OneTouch Verio Flex meter and the OneTouch Reveal app to patients to better manage diabetes.
Early Time-restricted Feeding Regimen Improves Glycemic Variability, Time in Range in Patients with Prediabetes, Obesity
ENDO 2023. The pattern of intermittent fasting improved glycemic measures in a weight-independent fashion after just 7 days, according to the study abstract.
The Impact of Ozempic in the US: 3 Takeaways from a Recent Survey
Nearly half of responding medical professionals said patients without T2D have asked for an Ozempic Rx and about 18% of them have provided one, avoiding significant backlash for a denial.
Daily Dose: Metformin Reduces Risk of Long COVID
Your daily dose of clinical news you may have missed.
Diabetes, Prediabetes, and Diabetes Duration Linked to Higher Risk of COPD, Death
Patients with diabetes had a 35% higher risk of COPD compared with those without diabetes, according to new research.
Metformin Reduced Long COVID Risk by About 40% vs Placebo in a New Phase 3 Trial
More research is needed to determine whether metformin is also effective in patients with lower body mass index or with previous infection, said researchers.
The Impact of Self Glucose Monitoring on Diabetes Treatment Goals
Eden Miller, DO, reviews the impact the BGM and diabetes management apps have on the patient, giving clinicians a better ability to personalize treatment and empower the patient.
Importance of Amount of Time Monitoring Diabetes
Experts discuss how the amount of time a patient spends engaging with the BGM and diabetes apps will contribute to managing their diabetes.
SGLT-2 Inhibitors Linked to Reduced Risk for Wide Range of Cancers in Study from Taiwan
Reduced risk for 10 different cancers was reported among patients with diabetes treated with SGLT2 inhibitors compared with those not treated.
Daily Dose: Prediabetes, Intervening Diabetes, & Subsequent Dementia Risk
Younger Age at Diabetes Onset Associated with Higher Risk of Dementia, According to New Study
Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.
App Engagement Data From Patients With Diabetes
Eden Miller, DO, highlights patient engagement with OneTouch Verio Flex meter and the OneTouch Reveal apps and how the data help to manage diabetes.
Overview of Data Outcomes in Diabetes Study
Elizabeth Holt, MD, FACE and Eden Miller, DO, review glycemic data over a 90-day and 180-day period in patients with diabetes.
Diabetes Associated with Higher Risk of Death in Persons Hospitalized with Acute Myocardial Infarction
After an acute myocardial infarction, adults with diabetes were over 50% more likely to die after 1 year than those without diabetes, a new study shows.
Daily Dose: Disparities in Diabetes Care
New Study Highlights Disparities in Diabetes Care between Urban, Rural Patients
New study found that patients living in urban areas were more likely to meet all aspects of key metrics of diabetes care.
Study of OneTouch Verio Flex® Meter and OneTouch Reveal® Mobile Application
Experts provide an overview of a study on the use of the OneTouch Verio Flex meter paired with the OneTouch Reveal mobile application in the management of diabetes.
Potential Benefits of Digital Tools in Diabetes Management
Elizabeth Holt, MD, FACE and Eden Miller, DO, comment on saving time for the provider and giving patients ownership of their data as benefits of using digital BGM apps in the management of diabetes.
Daily Dose: Rise in Diabetes-Related Vascular Deaths Linked to Renal Complications
Barriers to Use of Technology in Diabetes Management
Eden Miller, DO, highlights a lack of knowledge in both the patient and the prescriber as a barrier to effective use of BGM technology in diabetes, as well as the need for personalized care for patients.
2 Clarke Drive Cranbury, NJ 08512